Skip to main content
main-content

Rheumatoid arthritis

Diagnosis and screening

The importance of early diagnosis and treatment of inflammatory arthritis

In this Medicine Matters rheumatology podcast, we talk to President-Elect of EULAR Professor Iain McInnes, about the importance of early diagnosis and treatment of rheumatic diseases.

19-12-2018 | Diagnosis and screening | Podcast | Audio

The importance of early diagnosis and treatment of inflammatory arthritis

In this Medicine Matters rheumatology podcast, we talk to President-Elect of EULAR Professor Iain McInnes, about the importance of early diagnosis and treatment of rheumatic diseases.

19-11-2018 | Rheumatoid arthritis | News

Autoantibody positivity linked to favorable treatment outcomes in RA patients

Among patients with rheumatoid arthritis, a combination of anticitrullinated protein antibody and rheumatoid factor positivity is associated with faster treatment response and a greater likelihood of achieving remission, researchers report.

Source:

RMD Open 2018; 4: e000738

02-10-2018 | Rheumatoid arthritis | Review | Article

Diagnosis and management of rheumatoid arthritis: A review

Aletaha D, Smolen JS. JAMA 2018; 320: 1360–1372. doi: 10.1001/jama.2018.13103

07-09-2018 | Rheumatoid arthritis | Article

Characteristics of difficult-to-treat rheumatoid arthritis: Results of an international survey

Roodenrijs NMT et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213687

Clinical, ultrasound, and predictability outcomes following certolizumab pegol treatment (with methotrexate) in patients with moderate-to-severe rheumatoid arthritis: 52-week results from the CZP-SPEED study

The aim of this trial was to assess the impact of certolizumab pegol treatment on clinical, patient-reported, and musculoskeletal ultrasound outcomes in Italian patients with rheumatoid arthritis [read more].
Sarzi-Puttini P et al. Adv Ther 2018. doi: 10.1007/s12325-018-0751-8

02-08-2018 | Rheumatoid arthritis | Review | Article

Ultrasound and its clinical use in rheumatoid arthritis: Where do we stand?

do Prado AD et al. Adv Rheumatol 2018; 58: 19. doi: 10.1186/s42358-018-0023-y

The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients

The aim of this study is to determine which risk calculator correlates best with carotid ultrasound findings, specifically carotid plaque and carotid intima-media thickness in rheumatoid arthritis patients without clinical manifestations [read more]. 
Wah-Suarez MI et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4181-4

02-07-2018 | Rheumatoid arthritis | Article

The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients

The aim of this study is to determine which risk calculator correlates best with carotid ultrasound findings, specifically carotid plaque and carotid intima-media thickness in rheumatoid arthritis patients without clinical manifestations. 

Wah-Suarez MI et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4181-4

26-06-2018 | Rheumatoid arthritis | Review | Article

Preclinical rheumatoid arthritis and rheumatoid arthritis prevention

Deane KD. Curr Rheumatol Rep 2018; 20: 50. doi: 10.1007/s11926-018-0754-0

17-06-2018 | Rheumatoid arthritis | EULAR 2018 | News

Blood test predicts at-risk individuals likely to develop RA in the short term

Researchers have validated a blood test involving B-cell receptor clones that could determine which healthy individuals at risk for rheumatoid arthritis are likely to develop the condition in the short term.

Source:

EULAR 2018 meeting; Amsterdam, the Netherlands

15-06-2018 | Rheumatoid arthritis | EULAR 2018 | News

MRI monitoring of treated RA patients does not improve clinical and radiographic outcomes

Adding the additional target of no osteitis or bone marrow edema on magnetic resonance imaging to a conventional treat-to-target regimen does not improve the clinical or radiographic outcomes of rheumatoid arthritis patients in clinical remission, IMAGINE-RA study findings show.

Source:

EULAR 2018 meeting; Amsterdam, the Netherlands

11-06-2018 | Rheumatoid arthritis | Article

Leptin as an obesity marker in rheumatoid arthritis

Guimarães MFBR et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4082-5

08-06-2018 | Pain | Review | Article

Cannabinoids for the treatment of rheumatic diseases: Where do we stand?

Katz-Talmor D et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0025-5

image credits